Microwave Imaging in NeuroTrauma
NCT05960279 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2023-07-25
Summary
The study aims to investigate whether microwave-based technology can be used as a bedside decision-making aid to identify patients who may have a bleed in their head.
The MD100 is a microwave-based head scanner, developed for the purpose of detecting strokes. In clinical trials, it was noticed that the device performed better when the patient suffered a stroke due to a bleed. It was believed that this device had wider applications in trauma care.
The MD100 has demonstrated a very high level of accuracy in detecting bleeds in small clinical trials in the non-acute setting. The device is supported by software that determines the presence of a bleed.
This study will be set in the emergency department of major trauma centres. Patients that have sustained a head injury will be considered for enrollment into the study. Following a head CT scan, patients will be scanned by the MD100. The trial will run in two phases.
In phase one: the findings from the patient's head CT scan will be used to trial the device and teach the software what it is scanning. In phase two: The MD100 will be tested to see whether it can concur with the findings of the patient's CT scan, this will be used to determine the accuracy and reliability of the device.
Conditions
- Craniocerebral Trauma
Interventions
- DEVICE
-
MD100
The MD100 (Medfield Diagnostics, Gothenburg, Sweden) consists of 8 antennas and measurement electronics integrated into a single device; rechargeable ion batteries power the instrument. The radiation transmitted from the device equals approximately 1% of the radiation emitted from a mobile phone. The device is non-invasive and small enough that it can be moved around with ease. The system transmits microwaves with an output of 0.2 milliWatts (mW) for less than 90 seconds. The power absorbed by the body is 100mW/kg which is a factor of 200 less than what is established by the existing safety standard for microwaves. A mobile phone output, by comparison, can be up to 250mW. The patient's head is placed in the instrument during measurement while the patient is supine. The procedure takes, on average, 5 minutes to perform.
Sponsors & Collaborators
-
Air Ambulance Charity Kent, Surrey, Sussex
collaborator UNKNOWN -
St George's University Hospitals NHS Foundation Trust
collaborator OTHER -
Medfield Diagnostics AB
collaborator UNKNOWN -
King's College Hospital NHS Trust
lead OTHER
Principal Investigators
-
Malcom Tunnicliff, MBBS · King's College Hospital NHS Trust
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-07-20
- Primary Completion
- 2025-01-31
- Completion
- 2025-01-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Brain Blood Flow Studies of Language and Memory
NCT00001288 ·Status: COMPLETED
-
Detecting Chronic Subdural Hematoma With Microwave Technology
NCT02282228 ·Status: COMPLETED ·Phase: NA
-
TBI Multimodal Monitoring Study
NCT02993549 ·Status: UNKNOWN
-
The Role of MEG in Assessment and Diagnosis In mTBI
NCT03867513 ·Status: UNKNOWN
-
Metabolic Imaging of Neurological Disease
NCT06900244 ·Status: ENROLLING_BY_INVITATION
-
Platelet Bioenergetics in TBI
NCT04271059 ·Status: TERMINATED
-
Mild Head Trauma in the Emergency Room: Assessment of the Risk of Intracranial Hemorrhage in Patients Receving Platelet Inhibitors.
NCT05589103 ·Status: UNKNOWN
-
Prediction of Secondary Neurological Deterioration in Patients With Moderate Traumatic Brain Injury
NCT04854954 ·Status: COMPLETED
-
Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy
NCT01045044 ·Status: WITHDRAWN
-
The Value of Combined Detection of Different Blood Biomarkers in the Diagnosis and Treatments of Traumatic Brain Injury
NCT06854835 ·Status: NOT_YET_RECRUITING
-
Evaluating Near-infrared Spectroscopy Devices for Monitoring Traumatic Brain Injury
NCT07106216 ·Status: NOT_YET_RECRUITING
-
Functional MRI to Assess Brain Damage in Cardiac Arrest Patients
NCT05966389 ·Status: COMPLETED
-
Outcomes of Autologous Bone Marrow-derived Mononuclear Cell Transplantation in the Management of Neurological Sequelae
NCT05293873 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment and Outcome of Patients With Mild Head Injury
NCT07339319 ·Status: RECRUITING
-
Infiltration of Gadolinium Injection in Brain MR Scans Using Artificial Intelligence
NCT05235646 ·Status: COMPLETED
-
Near Infra-red Spectroscopy for Detection of Intracranial Haematoma
NCT03653728 ·Status: UNKNOWN
-
Near-infrared Spectroscopy (NIRS) for Intracranial Hematoma Detection
NCT05189561 ·Status: COMPLETED ·Phase: NA
-
Multi-Modality Imaging Standard Cohort Of Cerebrovascular Disease
NCT06925178 ·Status: RECRUITING
-
Biomarkers in Prehospital Rule-out of Intracranial Lesions in TBI Patients
NCT02867137 ·Status: COMPLETED
-
Imaging of Injury Mechanism and Interaction of Intestinal Bacteria in Children With Mild Traumatic Brain Injury
NCT05090007 ·Status: UNKNOWN
-
Supplementing Neuro-Energy to Aid Cognition
NCT06767124 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Interest of the S100B Protein Assay in Mild Traumatic Brain Injuries at the DOUAI Hospital
NCT05285774 ·Status: COMPLETED
-
Image Detection of Impaired Microcirculatory Reperfusion
NCT07099599 ·Status: RECRUITING
-
MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation
NCT05087888 ·Status: TERMINATED
-
Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II
NCT02317250 ·Status: WITHDRAWN ·Phase: PHASE3